Business Wire

Nucleus RadioPharma Expands Radiopharmaceutical Research, Development and Manufacturing Capacity, Addressing Nationwide Supply Chain Constraints

ROCHESTER, Minn.--(BUSINESS WIRE)--Nucleus RadioPharma today announced the development of two new facilities totaling over 100,000 square feet in Mesa, Arizona and Springhouse, Pennsylvania. These ...
News Medical

SwRI designs bed netting systems for mosquito-based malaria control

Southwest Research Institute tapped into its drug formulation and manufacturing expertise to fabricate two bed netting prototypes targeting malaria-causing blood parasites. In a collaboration with ...
JCN Newswire

Biologics License Application for Subcutaneous Formulation of "LEQEMBI(R)" (lecanemab) for the Treatment of Early Alzheimer's Disease Accepted in China

Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...
Pharmabiz

CDSCO approves highest number of new drugs with r-DNA origin for import & manufacture in 2025

Gireesh Babu, New Delhi Wednesday, January 21, 2026, 08:00 Hrs [IST] ...
Business Wire

CoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.

CLEARWATER, Fla.--(BUSINESS WIRE)--CoreRx, Inc. (“CoreRx”) today announced that it has completed its acquisition of Societal CDMO, Inc. (“Societal CDMO”) (Nasdaq: SCTL), a contract development and ...